19Feb/13

Novartis nabs another FDA-approved indication for everolimus – FiercePharma


MedPage Today

Novartis nabs another FDA-approved indication for everolimus
FiercePharma
Turns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everolimus is one of the Swiss drugmaker’s lead drugs in the …
FDA Approves Everolimus for Liver RejectionMedPage Today
Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE
Novartis drug Zortress is first in over a decade approved by FDA to prevent …PipelineReview.com (press release)
Monthly Prescribing Reference –Motley Fool –PharmaTimes
all 9 news articles »